tiprankstipranks
Crispr Therapeutics AG (CRSP)
NASDAQ:CRSP
Want to see CRSP full AI Analyst Report?

Compare Crispr Therapeutics AG (CRSP) vs. Competitors

10,912 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Crispr Therapeutics AG
$57.99
$5.17B
-9.29
40.08%
11 Buy
2 Hold
1 Sell
Moderate Buy
Intellia Therapeutics
$14.95
$1.64B
-2.54
56.90%
9 Buy
7 Hold
2 Sell
Moderate Buy
Apellis Pharmaceuticals
$40.90
$5.25B
-13.43
101.43%
2 Buy
17 Hold
0 Sell
Hold
Beam Therapeutics
$31.39
$3.09B
2.92
48.62%
11 Buy
1 Hold
0 Sell
Strong Buy
Legend Biotech
$21.17
$4.90B
-32.35
-20.11%
10 Buy
2 Hold
0 Sell
Strong Buy
Kymera Therapeutics
$87.71
$6.88B
-29.33
136.93%
15 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CRSP
Crispr Therapeutics AG
53.58
15.96
42.42%
NTLA
Intellia Therapeutics
13.87
5.43
64.34%
APLS
Apellis Pharmaceuticals
40.97
20.99
105.06%
BEAM
Beam Therapeutics
30.08
10.26
51.77%
LEGN
Legend Biotech
26.50
-6.90
-20.66%
KYMR
Kymera Therapeutics
83.59
50.01
148.93%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts